United States · Pre-seed startup

Who invested in Sift Biosciences

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$3.8Mraised across 1 round since 2025, from 1 source

Latest round
Pre-seed, $3.8MDec 2025
Investors
2
See who backed them

The rounds

  1. Dec 2025
    Pre-seed$3.8M

    Source recordedSEC filing: $3.8M sold, first sale Nov 2025

Founders and team

From Sift Biosciences's own website: 1 founder, 2 on the team.

Maddie WilliamsFounder & CTO
  • Andrew ConroyPrincipal Scientist
  • MaryClare RollinsSenior Scientist

Everyone who backed them

IsaiVC firm1round
Vision VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Sift Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Lifespan Vision VenturesVC firmPer its own site

Quick answers about Sift Biosciences

Who invested in Sift Biosciences?

Sift Biosciences's investors include Isai and Vision Ventures.

How much has Sift Biosciences raised?

Sift Biosciences has raised $3.8M across 1 round since 2025.

When did Sift Biosciences last raise?

Sift Biosciences's most recent round was a Pre-seed of $3.8M in Dec 2025.

What was Sift Biosciences's biggest round?

Its most recent round, $3.8M in Dec 2025, is also its largest on record.

Who backed Sift Biosciences first?

Sift Biosciences's first round on record, in Dec 2025, was backed by Isai and Vision Ventures.

What stage is Sift Biosciences at?

Sift Biosciences's latest named round is a Pre-seed, in Dec 2025.

Where is Sift Biosciences based?

Sift Biosciences is based in the United States.

Companies like Sift Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.